Other OTC Healthcare Products Market in Pakistan to 2014 (OTC Healthcare)
Price not available for India
You can still browse on Amazon. Try another country above.
Book Details
Author(s)
Datamonitor
Publisher
MarketResearch.com
ISBN / ASIN
B004VCFS1O
ISBN-13
978B004VCFS15
Marketplace
India 🇮🇳
Ratings & Reviews
No reviews yet — be the first!
No reviews yet.
Description
Introduction
This databook provides key data and information on the Other OTC Healthcare Products Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
Other OTC healthcare products category was valued at PKR4,617.8m ($65.6m) in 2009, representing a CAGR of 9.9% since 2004.
By the end of 2014, other OTC healthcare products category will be worth PKR6,345.8m ($90.1m), with an expected CAGR of 6.6% between 2009 and 2014.
Other OTC healthcare products market was led by rectal medications (representing 43.3% of the total value) followed by motion sickness and eye / ear drops, with a 25.7% and 13.6% market share, respectively. Anti-smoking aids and sleeping aids constitute the remaining segments with a 9.4% and 8% market share, respectively.
GlaxoSmithKline Plc is the market leader with a 6.8% share of the market.
Reasons to Purchase
This databook provides key data and information on the Other OTC Healthcare Products Market in Pakistan (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
Other OTC healthcare products category was valued at PKR4,617.8m ($65.6m) in 2009, representing a CAGR of 9.9% since 2004.
By the end of 2014, other OTC healthcare products category will be worth PKR6,345.8m ($90.1m), with an expected CAGR of 6.6% between 2009 and 2014.
Other OTC healthcare products market was led by rectal medications (representing 43.3% of the total value) followed by motion sickness and eye / ear drops, with a 25.7% and 13.6% market share, respectively. Anti-smoking aids and sleeping aids constitute the remaining segments with a 9.4% and 8% market share, respectively.
GlaxoSmithKline Plc is the market leader with a 6.8% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Other OTC Healthcare Products Market in Pakistan (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements
